OpenAlex
PricingAboutJobs
Log inGet started
Work

What evidence do we need for biomarker qualification?

HTML

Year: 2017
Type: article
Source: Science Translational Medicine
DOI: 10.1126/scitranslmed.aal4599
Authors: Chris Leptak, Joseph P. Menetski, John A. Wagner, Jiri Aubrecht, Linda Brady, Martha Brumfield, William W. Chin, Steve Hoffmann, Gary Kelloff, Gabriela Lavezzari, Rajesh Ranganathan, John-Michael Sauer, Frank D. Sistare, Tanja Zabka, David Wholley
Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research, Foundation for the National Institutes of Health, Pfizer (United States), National Institutes of Health, National Institute of Mental Health, Critical Path Institute, Pharmaceutical Research and Manufacturers of America, National Cancer Institute, Massachusetts General Hospital, Merck & Co., Inc., Rahway, NJ, USA (United States), Genentech
Language: English

Topic: Statistical Methods in Clinical Trials
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Keywords: biomarker qualification, evidence requirements, FDA regulatory framework, drug development, multi-stakeholder collaboration, regulatory science
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2768386871
FWCI: 5.986
Cites: 13
Cited by: 83
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security